Graft-vs.-Lymphoma Effect in Various Histologies of Non-Hodgkin's Lymphoma

References

• Branson, K., Chopra, R., Kottaridis, P.D., McQuaker, G., Parker, A., Schey, S., et al. (2002) "Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies", Journal of Clinical Oncology, 20, 4022–4031.
   Google Scholar
• Chapuis, B., Schmitz, N., Horowitz, MM., Gale, R.P., Goldman, J.M., Loberiza, F.R. Jr, et al. (2000) "Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation". IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT), Blood, 95, 3702— 3709.
   Google Scholar
• van Besien, K.W., de Lima, M., Giralt, S.A., Moore, D.F. Jr, Khouri, IF., Rondon, G., et al. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect", Bone Marrow Transplantation, 19, 977 — 982.
   PubMed Web of Science ®Google Scholar
• Or, R., Ackerstein, A., Nagler, A., Amar, A., Naparstek, E., Varadi, G., et al. (1998) "Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation", Journal of Immunotherapy, 21, 447–453.
   Google Scholar
• Bellucci, R., Alyea, E.P., Weller, E., Chillemi, A., Hochberg, E., Wu, CJ., et al. (2002) "Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma", Blood, 99, 4610–4617.
   Google Scholar
• International Bone Marrow Transplant Registry/Autologous Blood and Bone Marrow Transplant Registry. (2002) IBMTRIABMTR Newsletter 9, 12.
   Google Scholar
• Freedman, AS., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Fisher, D.C., et al. (1999) "Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma", Blood, 94, 3325— 3333.
   Google Scholar
• Colombat, P., Cornillet, P., Deconinck, E., Tourani, J.M., Gardembas, M., Delain, M., et al. (2000) "Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study", Bone Marrow Transplantation, 26, 971 — 977.
   PubMed Web of Science ®Google Scholar
• Schouten, H.C., Kvaloy, S., Sydes, M., Qian, W. and Fayers, P.M. (2000) "The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)", Annals of Oncology, 11\(Suppl. 1), 91–94.
   PubMed Web of Science ®Google Scholar
• van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, J.0., Bishop, M.R., et al. (1998) "Allogeneic bone marrow transplantation for low-grade lymphoma", Blood, 92, 1832— 1836.
   Google Scholar
• Hosing, C. and Champlin, R.E. (2002) "The choice of allogeneic or autologous hematopoietic transplantation for NHL", Cytotherapy, 4, 259–269.
   Google Scholar
• McSweeney, P.A., Niederwieser, D., Sliizuru, J., Sandmaier, B.M., Molina, A.J., Maloney, D.G., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects", Blood, 97, 3390— 3400.
   Google Scholar
• Toze, C.L., Shepherd, J.D., Connors, J.M., Voss, N.J., Gascoyne, R.D., Hogge, D.E., et al. (2000) "Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia", Bone Marrow Transplantation, 25, 605–612.
   PubMed Web of Science ®Google Scholar
• Corradini, P., Voena, C., Tarella, C., Astolfi, M., Ladetto, M., Palumbo, A., et al. (1999) "Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplanta-tion of hematopoietic cells", Journal of Clinical Oncology, 17, 208 — 215.
   Google Scholar
• Martinelli, G., Terragna, C., Zamagni, E., Ronconi, S., Tosi, P., Lemoli, R.M., et al. (2000) "Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma", Journal of Clinical Oncology, 18, 2273— 2281.
   Google Scholar
• Gahrton, G., Svensson, H., Cavo, M., Apperly, J., Bacigalupo, A., Bjorkstrand, B., et al. European Group for Blood and Marrow Transplantation. (2001) "Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed at European Group for Blood and Marrow Transplantation centres" 1983–93 and 1994–98 , British Journal of Haematology, 113, 209–216.
   Web of Science ®Google Scholar
• Maloney, D.G., Sandmaier, B.M., Mackinnon, S. and Shizuru, J.A. (2002) "Non-myeloablative transplantation", Hematology, (Am Soc Hematol Educ Program), 392–421.
   PubMedGoogle Scholar
• Maris, MB., Niederwieser, D., Sandmaier, B., et al. (2002) "Engraftment of nonmyeloablative hematopoietic stem cell trans-plants (HSCT) using marrow and PBSC from 10/10 HLA antigen matched unrelated donors (URDSs) for patients ineligible for conventional HSCT", Biology of Blood Marrow Transplantation, 8, 63 [abstract].
   Google Scholar
• Khouri, IF., Saliba, R.M., Giralt, S.A., Lee, M.S., Okoroji, G.J., Hagemeister, F.B., et al. (2001) "Nonablative allogeneic hemato-poietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality", Blood, 98, 3595 — 3599.
   Google Scholar
• Khouri, IF., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemother-apy and allogeneic blood progenitor-cell transplantation as treat-ment for lymphoid malignancies", Journal of Clinical Oncology, 16, 2817 — 2824.
   PubMed Web of Science ®Google Scholar
• Gandhi, V., Kemena, A., Keating, M.J. and Plunkett, W. (1993) "Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy", Leukemia and Lymphoma, 10, 49— 56.
   Google Scholar
• Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., LoBuglio, A.F., et al. (1999) "Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy", Journal of Clinical Oncology, 17, 268–276.
   PubMed Web of Science ®Google Scholar
• Gupta, D., Bybee, A., Cooke, F., Giles, C., Davis, J.G., McDonald, C., et al. (1999) "CD34 + -selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome", British Journal of Haematology, 104, 166 — 167.
   Web of Science ®Google Scholar
• Holmberg, L.A., Boeckh, M., Hooper, H., Leisenring, W., Rowley, S., Heimfeld, S., et al. (1999) "Increased incidence of cytomegalo-virus disease after autologous CD34-selected peripheral blood stem cell transplantation", Blood, 94, 4029–4035.
   PubMed Web of Science ®Google Scholar
• Stewart, AK., Vescio, R., Schiller, G., Ballester, 0., Noga, S., Rugo, H., et al. (2001) "Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial", Journal of Clinical Oncology, 19, 3771 — 2779.
   Web of Science ®Google Scholar